欧洲药物公司警告特朗普的关税 可能会把研究和制造工作转移到美国 European drug firms warn Trump's tariffs could move research and manufacturing jobs to the U.S.

欧洲制药公司通过EFPIA警告说,特朗普总统的关税可能会将药物研究和制造从欧洲推向美国。 European pharmaceutical companies, through the EFPIA, have warned that President Trump's tariffs may drive drug research and manufacturing from Europe to the US. 他们担心关税将使欧洲在获得资本和监管效率等领域与美国相比竞争力降低。 They fear the tariffs will make Europe less competitive compared to the US in areas like access to capital and regulatory efficiency. 该行业面临投资和研发支出损失1032亿欧元的风险。 The industry is at risk of losing €103.2 billion in investments and R&D spending. 他们呼吁欧盟紧急进行政策改革,以保持其竞争优势,避免制药部门大规模外流。 They are calling for urgent policy reforms from the EU to retain their competitive edge and avoid a mass exodus of the pharmaceutical sector.